Norovirus In-Vitro Time-Kill Evaluation

To evaluate commercial sanitizing products for their virucidal effectiveness against murine norovirus.
Funding Partners:
  • Applied BioCode, Inc.
  • Luminex Corporation
  • R-Biopharm Inc.
Previous Funding Partners:
  • American Society for Microbiology
  • Applied BioCode, Inc.
  • Arch Chemicals, Inc.
  • Byotrol Inc.
  • Cepheid
  • Clemson University
  • DiaSorin Inc.
  • Ecolab
  • GOJO Industries, Inc.
  • Holland America Line
  • ImpactRx, Inc.
  • Indusco Distribution of America, Inc.
  • International Atomic Energy Agency
  • Luminex Molecular Diagnostics, Inc.
  • Microbide Limited
  • Molnlycke Health Care, LLC
  • Nanosphere, Inc.
  • Oxoid Ltd.
  • Pathcon Laboratories
  • RADCO Chemical Solutions, Inc.
  • Takeda Pharmaceutical Company Limited
  • Takeda Pharmaceuticals U.S.A., Inc.
  • Therapeutic Goods Adminstration
  • University of North Carolina at Chapel Hill
  • The University of Queensland, Australia
Program Partners:
  • CDC's National Center for Immunization and Respiratory Diseases
Program Location:
  • United States of America